Silicon Valley Bank Provides $15MM Credit Facility to INmune Bio
INmune Bio, a clinical-stage immunology company focused on developing treatments that harness patients’ innate immune systems to fight disease, entered into a new $15 million credit facility with Silicon Valley Bank and an affiliate of SVB Financial Group.
June 15, 2021
David Szymkowski | INmune | RJ Tesi | Silicon Valley Bank | SVB Financial Group | Xencor
Ian Koplin